Literature DB >> 28437752

DNA repair and damage pathways in breast cancer development and therapy.

Maryam Majidinia1, Bahman Yousefi2.   

Abstract

DNA damage/repair constitutes several key pathways working in concert to eliminate DNA lesions and maintain genome stability and integrity. Defective components in DNA damage and repair machinery are an underlying cause for the development and progression of different types of cancers, and breast cancer is no exception. In this paper, we will briefly explain the importance of DNA damage and repair, introduce the current classification schemes for breast cancer, and review the known defects in the repair machinery that have been associated with the risk of breast cancer. Finally, we discuss how the understanding of these pathways can help to design therapeutics for specific targeting of breast cancer tumors.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Breast cancer; Chemotherapy; DNA damage; DNA repair

Mesh:

Year:  2017        PMID: 28437752     DOI: 10.1016/j.dnarep.2017.03.009

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  19 in total

1.  Identification of key differentially expressed genes between ER-positive/HER2-negative breast cancer and ER-negative/HER2-negative breast cancer using integrated bioinformatics analysis.

Authors:  Siyuan Gan; Haixia Dai; Rujia Li; Wang Liu; Ruifang Ye; Yanping Ha; Xiaoqing Di; Wenhua Hu; Zhi Zhang; Yanqin Sun
Journal:  Gland Surg       Date:  2020-06

2.  Ganoderma lucidum enhances carboplatin chemotherapy effect by inhibiting the DNA damage response pathway and stemness.

Authors:  Ivette J Suárez-Arroyo; Ariana Acevedo-Díaz; Tiffany J Ríos-Fuller; Gabriela Ortiz-Soto; Ricardo Vallejo-Calzada; Jael Reyes-Chea; Gerónimo Maldonado-Martínez; Robert J Schneider; Michelle M Martínez-Montemayor
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

Review 3.  DNA damage repair functions and targeted treatment in breast cancer.

Authors:  Chenfeng He; Kosuke Kawaguchi; Masakazu Toi
Journal:  Breast Cancer       Date:  2020-01-02       Impact factor: 4.239

Review 4.  MicroRNAs and DNA-Damaging Drugs in Breast Cancer: Strength in Numbers.

Authors:  Ilaria Plantamura; Giulia Cosentino; Alessandra Cataldo
Journal:  Front Oncol       Date:  2018-09-03       Impact factor: 6.244

5.  Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.

Authors:  Julia Böck; Silke Appenzeller; Larissa Haertle; Tamara Schneider; Andrea Gehrig; Jörg Schröder; Simone Rost; Beat Wolf; Claus R Bartram; Christian Sutter; Thomas Haaf
Journal:  Int J Cancer       Date:  2018-04-25       Impact factor: 7.396

6.  ATPase copper transporter A, negatively regulated by miR-148a-3p, contributes to cisplatin resistance in breast cancer cells.

Authors:  Ze Yu; Weifan Cao; Yuan Ren; Qijia Zhang; Jia Liu
Journal:  Clin Transl Med       Date:  2020-04-07

Review 7.  Global View of Candidate Therapeutic Target Genes in Hormone-Responsive Breast Cancer.

Authors:  Annamaria Salvati; Valerio Gigantino; Giovanni Nassa; Valeria Mirici Cappa; Giovanna Maria Ventola; Daniela Georgia Cristina Cracas; Raffaella Mastrocinque; Francesca Rizzo; Roberta Tarallo; Alessandro Weisz; Giorgio Giurato
Journal:  Int J Mol Sci       Date:  2020-06-06       Impact factor: 5.923

Review 8.  Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems.

Authors:  Maria Grazia Ferraro; Marialuisa Piccolo; Gabriella Misso; Francesco Maione; Daniela Montesarchio; Michele Caraglia; Luigi Paduano; Rita Santamaria; Carlo Irace
Journal:  Cells       Date:  2020-06-05       Impact factor: 6.600

9.  Functional Interaction Between BRCA1 and DNA Repair in Yeast May Uncover a Role of RAD50, RAD51, MRE11A, and MSH6 Somatic Variants in Cancer Development.

Authors:  Luisa Maresca; Samuele Lodovichi; Alessandra Lorenzoni; Tiziana Cervelli; Rossella Monaco; Laura Spugnesi; Mariella Tancredi; Elisabetta Falaschi; Katia Zavaglia; Elisabetta Landucci; Manuela Roncella; Caterina Congregati; Angiolo Gadducci; Antonio Giuseppe Naccarato; Maria Adelaide Caligo; Alvaro Galli
Journal:  Front Genet       Date:  2018-09-19       Impact factor: 4.599

10.  The association between the methylation frequency of BRCA1/2 gene promoter and occurrence and prognosis of breast carcinoma: A meta-analysis.

Authors:  Shu Li; Yong He; Chunli Li; Xing Liu; Yan Shen; Yang Wu; Ningjing Bai; Qiuhong Li
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.